IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Industrial Biotech

Solazyme's loss widens

3:15 PM MDT | May 8, 2013 | Rebecca Coons

Solazyme reported a GAAP net loss of $26.5 million for its fiscal first quarter ended 31 March, down from a net loss of $16.8 million in the prior-year period. On a non-GAAP basis, the net loss was $21.5 million, compared with a net loss of $12.8 million in the prior-year quarter. Sales fell 51%, to $6.7 million. The 2012 quarter included $5.5 million in government-funded revenues, Solazyme says. “We strengthened our financial position with over $250 million in new capital through a number of strategic initiatives including a successful convertible...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa